Are all CDK 4-6 created equal?

Date 24 March 2018
Event ESMO Symposium on Signalling Pathways in Cancer 2018
Session CDK4 and CDK6 inhibitors in breast cancer
Topics Breast Cancer
Pathology/Molecular Biology
Presenter Giuseppe Curigliano
Authors G. Curigliano
  • Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, 20141 - Milan/IT